Methyltrionete 5mg (MTR 1 vial) – Beligas EU

Description

Indications:
Metribolone is indicated in the treatment of certain conditions requiring an anabolic effect, such as cachexia or muscle wasting disorders. However, its use in medicine is limited and it is more frequently associated with bodybuilding and performance enhancement.

Contraindications:
Metribolone should be avoided in individuals with a history of anabolic steroid hypersensitivity, prostate cancer, male breast cancer, liver dysfunction, or cardiovascular disease, due to its aggravating potential.

Precautions:
Metribolone should be used with caution in individuals with a history of medical conditions such as hypertension, diabetes, or liver disease. Regular monitoring of blood pressure, liver function tests, and lipid profiles is recommended during treatment.

Drug interactions:
Metribolone may interact with anticoagulants, insulin, or oral hypoglycemic agents, affecting their efficacy and requiring dose adjustments. In addition, concomitant use with other hepatotoxic substances should be considered with caution to reduce the risk of liver injury.

Dosage:
The usual dosage of metribolone is 5 mg, administered intramuscularly or subcutaneously. Dosage may vary depending on individual goals, tolerance, and response. Beginners are often advised to start with lower doses to assess tolerance.

Conservation :
Store in a dark, dry place at room temperature. Do not refrigerate. Keep out of reach of children.

This medicine should only be administered on medical prescription!

Regulatory Compliance Statements:
This product complies with current regulatory guidelines. Certified according to Good Manufacturing Practices (GMP).

Safety information:
Overdose Instructions: In case of overdose, consult a doctor immediately.
Adverse reactions: Report any adverse reactions to your healthcare professional.